These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25376839)

  • 1. Changing the peptide specificity of a human T-cell receptor by directed evolution.
    Smith SN; Wang Y; Baylon JL; Singh NK; Baker BM; Tajkhorshid E; Kranz DM
    Nat Commun; 2014 Nov; 5():5223. PubMed ID: 25376839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtle changes at the variable domain interface of the T-cell receptor can strongly increase affinity.
    Sharma P; Kranz DM
    J Biol Chem; 2018 Feb; 293(5):1820-1834. PubMed ID: 29229779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific roles of each TCR hemichain in generating functional chain-centric TCR.
    Nakatsugawa M; Yamashita Y; Ochi T; Tanaka S; Chamoto K; Guo T; Butler MO; Hirano N
    J Immunol; 2015 Apr; 194(7):3487-500. PubMed ID: 25710913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell receptor (TCR)-peptide specificity overrides affinity-enhancing TCR-major histocompatibility complex interactions.
    Cole DK; Miles KM; Madura F; Holland CJ; Schauenburg AJ; Godkin AJ; Bulek AM; Fuller A; Akpovwa HJ; Pymm PG; Liddy N; Sami M; Li Y; Rizkallah PJ; Jakobsen BK; Sewell AK
    J Biol Chem; 2014 Jan; 289(2):628-38. PubMed ID: 24196962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasticity in the contribution of T cell receptor variable region residues to binding of peptide-HLA-A2 complexes.
    Smith SN; Sommermeyer D; Piepenbrink KH; Blevins SJ; Bernhard H; Uckert W; Baker BM; Kranz DM
    J Mol Biol; 2013 Nov; 425(22):4496-507. PubMed ID: 23954306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The basis for limited specificity and MHC restriction in a T cell receptor interface.
    Piepenbrink KH; Blevins SJ; Scott DR; Baker BM
    Nat Commun; 2013; 4():1948. PubMed ID: 23736024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategic mutations in the class I major histocompatibility complex HLA-A2 independently affect both peptide binding and T cell receptor recognition.
    Baxter TK; Gagnon SJ; Davis-Harrison RL; Beck JC; Binz AK; Turner RV; Biddison WE; Baker BM
    J Biol Chem; 2004 Jul; 279(28):29175-84. PubMed ID: 15131131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide recognition by two HLA-A2/Tax11-19-specific T cell clones in relationship to their MHC/peptide/TCR crystal structures.
    Hausmann S; Biddison WE; Smith KJ; Ding YH; Garboczi DN; Utz U; Wiley DC; Wucherpfennig KW
    J Immunol; 1999 May; 162(9):5389-97. PubMed ID: 10228016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structures of MART-126/27-35 Peptide/HLA-A2 complexes reveal a remarkable disconnect between antigen structural homology and T cell recognition.
    Borbulevych OY; Insaidoo FK; Baxter TK; Powell DJ; Johnson LA; Restifo NP; Baker BM
    J Mol Biol; 2007 Oct; 372(5):1123-36. PubMed ID: 17719062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TCR-induced alteration of primary MHC peptide anchor residue.
    Madura F; Rizkallah PJ; Legut M; Holland CJ; Fuller A; Bulek A; Schauenburg AJ; Trimby A; Hopkins JR; Wells SA; Godkin A; Miles JJ; Sami M; Li Y; Liddy N; Jakobsen BK; Loveridge EJ; Cole DK; Sewell AK
    Eur J Immunol; 2019 Jul; 49(7):1052-1066. PubMed ID: 31091334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions.
    Robbins PF; Li YF; El-Gamil M; Zhao Y; Wargo JA; Zheng Z; Xu H; Morgan RA; Feldman SA; Johnson LA; Bennett AD; Dunn SM; Mahon TM; Jakobsen BK; Rosenberg SA
    J Immunol; 2008 May; 180(9):6116-31. PubMed ID: 18424733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MHC allele-specific molecular features determine peptide/HLA-A2 conformations that are recognized by HLA-A2-restricted T cell receptors.
    Wang Z; Turner R; Baker BM; Biddison WE
    J Immunol; 2002 Sep; 169(6):3146-54. PubMed ID: 12218132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conserved CDR3 regions in T-cell receptor (TCR) CD8(+) T cells that recognize the Tax11-19/HLA-A*0201 complex in a subject infected with human T-cell leukemia virus type 1: relationship of T-cell fine specificity and major histocompatibility complex/peptide/TCR crystal structure.
    Bourcier KD; Lim DG; Ding YH; Smith KJ; Wucherpfennig K; Hafler DA
    J Virol; 2001 Oct; 75(20):9836-43. PubMed ID: 11559817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-affinity, peptide-specific T cell receptors can be generated by mutations in CDR1, CDR2 or CDR3.
    Chlewicki LK; Holler PD; Monti BC; Clutter MR; Kranz DM
    J Mol Biol; 2005 Feb; 346(1):223-39. PubMed ID: 15663940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparate degrees of hypervariable loop flexibility control T-cell receptor cross-reactivity, specificity, and binding mechanism.
    Scott DR; Borbulevych OY; Piepenbrink KH; Corcelli SA; Baker BM
    J Mol Biol; 2011 Dec; 414(3):385-400. PubMed ID: 22019736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell receptor engineering.
    Stone JD; Chervin AS; Aggen DH; Kranz DM
    Methods Enzymol; 2012; 503():189-222. PubMed ID: 22230570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a crucial energetic footprint on the alpha1 helix of human histocompatibility leukocyte antigen (HLA)-A2 that provides functional interactions for recognition by tax peptide/HLA-A2-specific T cell receptors.
    Baker BM; Turner RV; Gagnon SJ; Wiley DC; Biddison WE
    J Exp Med; 2001 Mar; 193(5):551-62. PubMed ID: 11238586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad TCR repertoire and diverse structural solutions for recognition of an immunodominant CD8
    Song I; Gil A; Mishra R; Ghersi D; Selin LK; Stern LJ
    Nat Struct Mol Biol; 2017 Apr; 24(4):395-406. PubMed ID: 28250417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational design of the affinity and specificity of a therapeutic T cell receptor.
    Pierce BG; Hellman LM; Hossain M; Singh NK; Vander Kooi CW; Weng Z; Baker BM
    PLoS Comput Biol; 2014 Feb; 10(2):e1003478. PubMed ID: 24550723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling a hotspot for TCR recognition on HLA-A2: evidence against the existence of peptide-independent TCR binding determinants.
    Gagnon SJ; Borbulevych OY; Davis-Harrison RL; Baxter TK; Clemens JR; Armstrong KM; Turner RV; Damirjian M; Biddison WE; Baker BM
    J Mol Biol; 2005 Oct; 353(3):556-73. PubMed ID: 16197958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.